Advertisement
Advertisement


Medical News

Researchers to Test if Alcohol, Cocaine Addiction Drug Can Reduce Latent HIV Reservoirs

February 23, 2011

Researchers from the University of California, San Francisco, and Johns Hopkins University are recruiting patients to examine whether a drug prescribed to treat alcohol and cocaine addiction can reduce the amount of latent HIV among HIV-positive patients already taking combination therapy, Bloomberg reports. "The researchers plan to add [the drug] Antabuse to the patients' regular cocktail of AIDS drugs for two weeks, then check their blood after 24 weeks to see whether it has depleted the amount of latent HIV," according to the news service. The trial is expected to conclude in June 2012, according to ClinicalTrials.gov (Bennett, 2/22).

Back to other news for February 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement